Search for other papers by Hua Luo in
Google Scholar
PubMed
Search for other papers by Chaojun Shen in
Google Scholar
PubMed
Search for other papers by Tongyou Qu in
Google Scholar
PubMed
Search for other papers by Lin Chen in
Google Scholar
PubMed
Search for other papers by Yue Sun in
Google Scholar
PubMed
Search for other papers by Yu Ren in
Google Scholar
PubMed
is the main form of adverse reactions, such as brain toxicity. Drug-induced seizures often begin as isolated acute seizures but may potentially progress to persistent seizures. Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine
Search for other papers by Hua Luo in
Google Scholar
PubMed
Search for other papers by Xuelei Zhang in
Google Scholar
PubMed
Department of Orthopedic, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China
Search for other papers by Chengxin Xie in
Google Scholar
PubMed
Search for other papers by Luxia Wu in
Google Scholar
PubMed
Search for other papers by Guoping Cai in
Google Scholar
PubMed
Search for other papers by Yu Ren in
Google Scholar
PubMed
spaces. Therefore, spinal surgeries cause a lot of bleeding and it is critical to address this intra- and post-operative bleeding. Tranexamic acid (TXA) is a synthetic lysine derivative that competitively inhibits plasminogen adsorption on fibrin and
Search for other papers by Hua Luo in
Google Scholar
PubMed
Search for other papers by Xueli Yan in
Google Scholar
PubMed
Search for other papers by Yu Ren in
Google Scholar
PubMed
Search for other papers by Han Zhang in
Google Scholar
PubMed
Search for other papers by Wenjun Pan in
Google Scholar
PubMed
autologous blood transfusion devices, as well as surgical modifications to reduce soft tissue damage. Tranexamic acid (TXA), as a synthetic antifibrinolytic drug, has been shown to significantly reduce bleeding during surgery in many surgical procedures. Its
Department of Pharmaceutical, Lanzhou University Second Hospital, Lanzhou, Gansu province, P.R. China
Search for other papers by Xiangji Dang in
Google Scholar
PubMed
Search for other papers by Mei Liu in
Google Scholar
PubMed
Search for other papers by Qiang Yang in
Google Scholar
PubMed
Search for other papers by Jin Jiang in
Google Scholar
PubMed
Search for other papers by Yan Liu in
Google Scholar
PubMed
Search for other papers by Hui Sun in
Google Scholar
PubMed
Search for other papers by Jinhui Tian in
Google Scholar
PubMed
preexisting thromboembolic risk profile. It is imperative to delve into these determinants comprehensively, exploring their individual and collective impact on patients undergoing TJA. Tranexamic acid (TXA), a potent antifibrinolytic agent, has become
Search for other papers by Dieter Wirtz in
Google Scholar
PubMed
Search for other papers by Hendrik Kohlhof in
Google Scholar
PubMed
, the blood loss is reduced by approximately 20–25%, but improved wound healing has also been reported. 6 – 7 As a lysine analogue, tranexamic acid suppresses fibrinolytic activity by competitively inhibiting the binding of plasminogen and plasmin
Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Search for other papers by Marcel Niemann in
Google Scholar
PubMed
Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Search for other papers by Ellen Otto in
Google Scholar
PubMed
Search for other papers by Christian Eder in
Google Scholar
PubMed
Search for other papers by Yasmin Youssef in
Google Scholar
PubMed
Search for other papers by Lutz Kaufner in
Google Scholar
PubMed
Search for other papers by Sven Märdian in
Google Scholar
PubMed
-induced coagulopathy is one of the leading causes of mortality among these patients ( 2 ), management beyond surgical measures gained further importance ( 3 ). Besides the early application of tranexamic acid (TXA) for trauma-induced bleeding patients, physicians
Search for other papers by Luigi Zagra in
Google Scholar
PubMed
is not justified nowadays. The use of tranexamic acid has been very effective in minimising the need for blood transfusions following THA. 21 , 22 Its increasing use has almost eliminated the need for other blood conservation strategies such as
Search for other papers by Stefan Lazic in
Google Scholar
PubMed
Search for other papers by Oliver Boughton in
Google Scholar
PubMed
Search for other papers by Catherine F. Kellett in
Google Scholar
PubMed
Search for other papers by Deiary F. Kader in
Google Scholar
PubMed
Search for other papers by Loïc Villet in
Google Scholar
PubMed
MSK Lab, Imperial College London, UK
Search for other papers by Charles Rivière in
Google Scholar
PubMed
Intra-operatively, tranexamic acid has proven to be effective and safe for haemostasis in TJA and is now considered as a game-changer for blood loss management. 53 The effects of tourniquet use are unclear at present, with earlier systematic reviews
Search for other papers by Felix Christoph Finger in
Google Scholar
PubMed
Osteotomie Komitee der Deutschen Knie Gesellschaft (DKG), Munich, Germany
Search for other papers by Steffen Schröter in
Google Scholar
PubMed
Search for other papers by Christoph Ihle in
Google Scholar
PubMed
Search for other papers by Moritz Herbst in
Google Scholar
PubMed
Search for other papers by Tina Histing in
Google Scholar
PubMed
Osteotomie Komitee der Deutschen Knie Gesellschaft (DKG), Munich, Germany
AO Research Institute Davos, Davos, Switzerland
Search for other papers by Marc-Daniel Ahrend in
Google Scholar
PubMed
growing evidence for the use of tranexamic acid (TXA) for osteotomies. A systematic review by Bierke et al. confirmed a lower hemoglobin decrease, less total blood loss and lower drainage volume when using TXA during osteotomies at knee level, compared
Search for other papers by Pietro Feltri in
Google Scholar
PubMed
Search for other papers by Camilla Mondini Trissino da Lodi in
Google Scholar
PubMed
Search for other papers by Alberto Grassi in
Google Scholar
PubMed
Search for other papers by Stefano Zaffagnini in
Google Scholar
PubMed
Facoltà di Scienze Biomediche, Università della Svizzera Italiana, Lugano, Switzerland
Search for other papers by Christian Candrian in
Google Scholar
PubMed
Applied and Translational Research Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Facoltà di Scienze Biomediche, Università della Svizzera Italiana, Lugano, Switzerland
Search for other papers by Giuseppe Filardo in
Google Scholar
PubMed
their clinical consequences, identifying patients at more risk, and evaluating all the available strategies for reducing bleeding, such as tranexamic acid, which is safely and successfully used for knee surgery. 44 - 46 The meta-analysis supported the